Global Genomic Testing in Cancer Market Growth (Status and Outlook) 2024-2030
According to this study, the global Genomic Testing in Cancer market size will reach US$ million by 2030.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomic Testing in Cancer market by product type, application, key players and key regions and countries.
Segmentation by product type:
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Segmentation by Application:
General Hospitals
Specialty Clinics
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Genomic Testing in Cancer Key Players
- 4 Genomic Testing in Cancer by Regions
- 5 United States
- 6 Europe
- 7 China
- 8 Rest of World
- 9 Market Drivers, Challenges and Trends
- 10 Key Investors in Genomic Testing in Cancer
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook